Y. Özalp Et Al. , "Quality by Design (QbD) Approach and Application of Preformulation Studies for a Poorly Water Soluble Model Drug, Nimesulid," ACTA FARMACEUTICA BONAERENSE , vol.42, no.1, pp.1-8, 2023
Özalp, Y. Et Al. 2023. Quality by Design (QbD) Approach and Application of Preformulation Studies for a Poorly Water Soluble Model Drug, Nimesulid. ACTA FARMACEUTICA BONAERENSE , vol.42, no.1 , 1-8.
Özalp, Y., Khamis, H., Jiwa, N., Mesut, B., & Aksu, N. B., (2023). Quality by Design (QbD) Approach and Application of Preformulation Studies for a Poorly Water Soluble Model Drug, Nimesulid. ACTA FARMACEUTICA BONAERENSE , vol.42, no.1, 1-8.
Özalp, Yıldız Et Al. "Quality by Design (QbD) Approach and Application of Preformulation Studies for a Poorly Water Soluble Model Drug, Nimesulid," ACTA FARMACEUTICA BONAERENSE , vol.42, no.1, 1-8, 2023
Özalp, Yıldız Et Al. "Quality by Design (QbD) Approach and Application of Preformulation Studies for a Poorly Water Soluble Model Drug, Nimesulid." ACTA FARMACEUTICA BONAERENSE , vol.42, no.1, pp.1-8, 2023
Özalp, Y. Et Al. (2023) . "Quality by Design (QbD) Approach and Application of Preformulation Studies for a Poorly Water Soluble Model Drug, Nimesulid." ACTA FARMACEUTICA BONAERENSE , vol.42, no.1, pp.1-8.
@article{article, author={Yıldız Özalp Et Al. }, title={Quality by Design (QbD) Approach and Application of Preformulation Studies for a Poorly Water Soluble Model Drug, Nimesulid}, journal={ACTA FARMACEUTICA BONAERENSE}, year=2023, pages={1-8} }